卷曲受体蛋白4在高脂血症大鼠种植体周围组织中的早期表达

doi:10.6040/j.issn.1671-7554.0.2019.830

摘要/Abstract

摘要： 目的探讨卷曲受体蛋白4(Frizzled4)在高脂血症大鼠种植体周围组织中早期的表达。方法 48只成年雄性SD大鼠,随机分为实验组和对照组,每组24只。分别喂食高脂饲料和普通饲料8周。均于股骨干骺端植入直径1.5 mm、长2.5 mm的种植体。分别于术后第1天、第3天、第5天和第28天时处死大鼠,获取种植体周围骨组织。用Inveon MM CT扫描组织标本,扫描完成后将图像中种植体周围1 mm区域设置为兴趣区(ROI),进行ROI内三维重建,分析骨小梁参数:骨小梁体积/ROI体积(BV/TV)、骨小梁厚度(Tb.Th)、骨小梁数目(Tb.N)、骨小梁间隙(Tb.S)。RT-PCR法检测成骨细胞、破骨细胞分化标志物Runt相关转录因子2(RUNX2)、组织蛋白酶K(CTSK)和Frizzled4的基因表达情况,Western blotting法检测Frizzled4蛋白表达情况。结果实验组种植体植入第1天、第3天时,实验组和对照组BV/TV、Tb.S、Tb.Th和Tb.N比较差异无统计学意义(P>0.05)。植入第5天、第28天时,实验组BV/TV、Tb.Th和Tb.N均低于对照组,而Tb.S高于对照组,差异有统计学意义(P<0.05)。实验组种植体植入第1天、第3天、第5天和第28天后,Runx2 mRNA表达水平均低于对照组,而CTSK mRNA表达水平高于对照组,差异有统计学意义(P<0.05)。对照组种植体植入3 d内,Frizzled4 mRNA和蛋白表达水平明显增加,第5天、第28天时有所下降,但是仍高于实验组(P<0.05)。实验组植入3 d内,Frizzled4 mRNA和蛋白表达水平明显下降,并且在第5天、第28天时升高(P<0.05)。对照组种植体植入3 d内,Wnt/β-catenin蛋白表达水平明显增加,第5天,第28天时有所下降,但是仍高于实验组(P<0.05)。实验组植入3 d内,Wnt/β-catenin蛋白表达水平显著上升,并且在第5天、第28天下降(P<0.05)。结论高脂血症可抑制种植体的早期骨结合,这种作用可能与下调Frizzled4的表达有关,未来需要进一步地进行机制研究。

关键词: 卷曲受体蛋白4, 高脂血症, 种植体, 骨结合

Abstract: Objective To investigate the early expression of Frizzled 4 in peri-implant tissues of hyperlipidemic rats. Methods A total of 48 adult male SD rats were randomly divided into two groups, with 24 rats in either group. Rats in the experimental group were fed with high fat diet, while rats in the control group were fed with common diet for 8 weeks. Implants 1.5 mm wide and 2.5 mm long were implanted into the metaphyseal end of femur. The rats were sacrificed on the 1st, 3rd, 5th and 28th days after operation to obtain bone tissues around the implant. The tissues were scanned with Inveon MM CT and 1 mm area around the implant was set as the area of interest(ROI). Three-dimensional reconstruction was performed in ROI. Bone trabecular parameters were analyzed, including trabecular volume/ROI volume(BV/TV), trabecular thickness(Tb.Th), trabecular number(Tb.N)and trabecular space(Tb.S). The gene expressions of osteoblasts, osteoclast differentiation markers Runt-related transcription factor 2(RUNX2), cathepsin K(CTSK)and Frizzled 4 were detected with RT-PCR. The protein expression of Frizzled 4 was determined with Western 山东大学学报 (医学版)58卷2期 -李源,等.卷曲受体蛋白4在高脂血症大鼠种植体周围组织中的早期表达 \=- blotting. Results There were no significant differences in BV/TV, Tb.S, Tb.Th and Tb.N between the two groups on the 1st and 3rd day of implantation(P>0.05). On the 5th and 28th days of implantation, the experimental group had lower BV/TV, Tb.Th and Tb.N but higher Tb.S than the control group(P<0.05). On the 1st, 3rd, 5th and 28th days of implantation, the experimental group had lower mRNA expression of Runx2 but higher mRNA expression of CTSK than the control group(P<0.05). In the control group, the mRNA and protein expressions of Frizzled 4 increased significantly on the 3rd day of implantation, and decreased on the 5th and 28th days, but were still higher than those in the experimental group(P<0.05). In the experimental group, both mRNA and protein expressions of Frizzled 4 decreased significantly on the 3rd day of implantation, but increased on the 5th and 28th days(P<0.05). In the control group, the protein expression of Wnt/β-catenin increased significantly on the 3rd day of implantation, and decreased on the 5th and 28th days, but was still higher than that in the experimental group(P<0.05). In the experimental group, the expression of Wnt/β-catenin increased significantly on the 3rd day of implantation, but decreased on the 5th and 28th days(P<0.05). Conclusion Hyperlipidemia can inhibit early osseointegration of implants, which may be related to the down-regulation of Frizzled 4 expression. The exact mechanism needs further research.

Key words: Frizzled 4, Hyperlipidemia, Implants, Osteointegration

中图分类号:

R782

李源,王强,石晓蕾,张晓丽,徐欣. 卷曲受体蛋白4在高脂血症大鼠种植体周围组织中的早期表达[J]. 山东大学学报 (医学版), 2020, 58(2): 29-35.

LI Yuan, WANG Qiang, SHI Xiaolei, ZHANG Xiaoli, XU Xin. Early expression of Frizzled 4 in peri-implant tissues of hyperlipidemic rats[J]. Journal of Shandong University (Health Sciences), 2020, 58(2): 29-35.

参考文献 25

[1]	Antonoglou GN, Stavropoulos A, Samara MD, et al. Clinical performance of dental implants following sinus floor augmentation: a systematic review and meta-analysis of clinical trials with at least 3 years of follow-up [J]. Int J Oral Maxillofac Implants, 2018, 33(3): 45-65.
[2]	Ragucci GM, Elnayef B, Su(~overa)rez-L(~overo)pez Del Amo F, et al. Influence of exposing dental implants into the sinus cavity on survival and complications rate: a systematic review[J]. Int J Implant Dent, 2019, 5(1): 6-13.
[3]	Savvidis C, Tournis S, Dede AD. Obesity and bone metabolism [J]. Hormones(Athens), 2018, 17(2): 205-217.
[4]	Keuroghlian A, Barroso ADV, Kirikian G, et al. The effects of hyperlipidemia on implant osseointegration in the mouse femur [J]. J Oral Implantol, 2015, 41(2): 7-11.
[5]	Insua A, Monje A, Wang H, et al. Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss [J]. J Biomed Mater Res A, 2017,105(7): 2075-2089.
[6]	Strakova K, Matricon P, Yokota C, et al. The tyrosine Y250(2.39)in Frizzled 4 defines a conserved motif important for structural integrity of the receptor and recruitment of Disheveled [J]. Cellular Signaling, 2017, 38: 85-96. doi: 10.1016/j.cellsig.2017.06.018.
[7]	Liu F, Wang Z, Liu F, et al. MicroRNA-29a-3p enhances dental implant osseointegration of hyperlipidemic rats via suppressing dishevelled 2 and frizzled 4 [J]. Cell Biosci, 2018, 8: 55. doi:10.1186/s13578-018-0254-y.
[8]	Ji H, Liu Y, He F, et al. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats [J]. J Pharm Biomed Anal, 2018, 156(1): 104-115.
[9]	Parwin A, Najmi AK, Ismail MV, et al. Protective effects of alendronate in Triton X-100-induced hyperlipidemia in rats [J]. Turk J Gastroenterol, 2019, 30(6): 557-564.
[10]	Ma XY, Wen XX, Yang XJ, et al. Ophiopogonin D improves osteointegration of titanium alloy implants under diabetic conditions by inhibition of ROS overproduction via Wnt/β-catenin signaling pathway [J]. Biochimie, 2018, 152(1): 31-42.
[11]	Magán-Fernández A, Papay-Ramírez L, Tomás J, et al. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers [J]. J Periodontol, 2015, 85(10): 1408-1415.
[12]	Shibamoto A, Ogawa T, Duyck J, et al. Effect of high-frequency loading and parathyroid hormone administration on peri-implant bone healing and osseointegration [J]. Int J Oral Sci, 2018, 10(1): 6-13.
[13]	López-Gómez JJ,Izaola-Jauregui O,Primo-Martín D, et al. Effect of weight loss on bone metabolism in postmenopausal obese women with osteoarthritis [J]. Obes Res Clin Pract, 2019, 13(4): 378-384.
[14]	Marozik P, Alekna V, Rudenko E, et al. Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis [J]. PLoS One, 2019, 14(8): 221-226.
[15]	Shigenobu K, Hashimoto T, Kanayama M, et al. The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing-In comparison with weekly teriparatide with bisphosphonate [J]. Bone Reports, 2019, 11(6): 100-106.
[16]	Yao RH, Nishii K,Kito T, et al. A novel device to prevent osteoporosis by promoting bone metabolism using a newly developed double-loading stimulation with vibration and shaking [J]. Okajimas Folia Anat Jpn, 2019, 96(1): 13-21.
[17]	Zhang Y, Zhou L, Li S, et al. Impacts of lead exposure and chelation therapy on bone metabolism during different developmental stages of rats [J]. Ecotoxicol Environ Saf, 2019, 183(14): 104-113.
[18]	I ngvild KBH,Stephen H,Monica CK,et al. Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass [J]. Bone, 2019, 127(6): 436-445.
[19]	Lee S, Le NH, Kang D. Melatonin alleviates oxidative stress-inhibited osteogenesis of human bone marrow-derived mesenchymal stem cells through AMPK activation [J]. Int J Med Sci, 2018, 15(1): 1083-1091.
[20]	Zhuang Y, Mao JQ, Yu M, et al. Hyperlipidemia induces vascular smooth muscle cell proliferation involving Wnt/β-catenin signaling [J]. Cell Biol Int, 2015, 40(2): 121-130.
[21]	Song HB, Jiang Y, Liu JX, et al. Stimulation of osteogenic differentiation in bone marrow stromal cells via Wnt/β-catenin pathway by Qili Jiegu-containing serum [J]. Biomed Pharmacother, 2018, 103(1): 1664-1668.
[22]	Bisson SK, Ung RV, Mac-Way F. Role of the Wnt/β-catenin pathway in renal osteodystrophy [J]. Int J Endocrinol, 2018, 16(5): 1-8.
[23]	Long H, Sun B, Cheng L, et al. miR-139-5p represses BMSC osteogenesis via targeting Wnt/β-catenin signaling pathway [J]. DNA Cell Biol, 2017, 36(8): 715-724.
[24]	Fu HD, Wang BK, Wan ZQ, et al. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation [J]. J Mol Histol, 2016, 47(5): 455-466.
[25]	Cédric L, Aline M, Marie-Thérèse L, et al. Fat and sucrose intake induces obesity-related bone metabolism disturbances: kinetic and reversibility studies in growing and adult rats [J]. J Bone Miner Res, 2016, 31(1): 98-115.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed